Promising Results for Iopofosine I 131 in Waldenstrom's Macroglobulinemia Study
1 Mins read
Shares of Cellectar Biosciences rose by 21% to reach a 52-week high of $3.29 following the announcement of positive topline data in…
Promising Results in Moderna's Personalized Cancer Treatment
2 Mins read
Moderna recently shared updated data from an ongoing early-stage trial of its personalized cancer treatment developed in collaboration with Merck. These new…